With a host of new drugs in development, and a skyrocketing stock, can it keep going higher? » Subscribe to CNBC: » Watch more …
source CNBC
ISIS Pharmaceuticals CEO: Biotech Is Back | Mad Money | CNBC
previous post
With a host of new drugs in development, and a skyrocketing stock, can it keep going higher? » Subscribe to CNBC: » Watch more …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More